Asset
Acetaminophen
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
Revenue
No revenue reported in loaded filings.
Clinical trials (20)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02311881 | phase3 | completed | 2015-01-01 | 2016-02-01 | GlaxoSmithKline | A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis |
| NCT01332578 | phase4 | completed | 2011-05-01 | 2011-06-01 | GlaxoSmithKline | A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies |
| NCT01551797 | phase1 | completed | 2010-05-01 | 2010-10-01 | GlaxoSmithKline | A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations. |
| NCT02678234 | phase3 | withdrawn | 2017-02-01 | 2017-04-01 | GlaxoSmithKline | An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu |
| NCT02730364 | phase3 | withdrawn | 2017-02-01 | 2017-04-01 | GlaxoSmithKline | An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| ANDA 083951 | ANDA | GLAXOSMITHKLINE |
Marketed products (2)
- EMPRACET W/ CODEINE PHOSPHATE #3
- EMPRACET W/ CODEINE PHOSPHATE #4